Related Experiment Video
Updated: May 10, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Tumor-induced host immunosuppression: special focus on CLL
1University of Nebraska at Omaha, Department of Biology, Omaha, NE 68182-0040, USA. ccutucache@unomaha.edu
International Immunopharmacology
|June 12, 2013
Summary
Malignant cells evade immune detection by suppressing immune responses. This review explores immune evasion in chronic lymphocytic leukemia (CLL) and strategies to counter tumor-induced immunosuppression.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Malignant cells employ diverse strategies to evade host immune surveillance.
- Tumor-induced immunosuppression operates at molecular, cellular, and physiological levels.
- Understanding immune evasion is critical for developing effective cancer therapies.
Purpose of the Study:
- To review the role of immune-tolerant genes and regulatory cells in tumor-induced immunosuppression.
- To examine alterations in T-cells and antigen presentation contributing to immune evasion.
- To highlight advances in countering immunosuppression, focusing on chronic lymphocytic leukemia (CLL) and its microenvironment.
Main Methods:
- Literature review of immune evasion mechanisms in cancer.
- Analysis of molecular and cellular pathways involved in immunosuppression.
- Examination of therapeutic strategies targeting the tumor microenvironment.
Main Results:
- Immune evasion involves modulation of T-cells and antigen presentation by malignant cells.
- Chronic lymphocytic leukemia (CLL) cells utilize specific immune evasion tactics.
- Targeting the tumor microenvironment presents challenges but offers therapeutic potential.
Conclusions:
- Targeting tumor-induced immunosuppression is a promising therapeutic avenue.
- Immunomodulatory drugs show potential in overcoming immune evasion.
- Further research into CLL-microenvironment interactions is needed to enhance treatment efficacy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:40Cell-mediated Immune Responses
Overview
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...